Jan 17, 2026
What are the out-of-pocket costs patients face for 2025 FDA-approved Alzheimer’s drugs?
Patients prescribed 2025 FDA‑approved Alzheimer’s drugs face variable but often substantial out‑of‑pocket exposure that depends on the drug’s list price, Medicare cost‑sharing rules, required diagnost...